To put it this way, Beckman Coulter is the largest medical enterprise in the hands of Danaher after it was acquired by Danaher. Prior to that, Beckman Coulter acquired the clinical diagnostics division of Olympus and launched the AU480\680\5800 series of biochemicals, which are manufactured at the Mishima plant in Japan, while the reagents are produced in Ireland.
In the face of such a large global market share, just one factory in Ireland is certainly not enough, and Ireland, because of its geographic location, serving European countries, is certainly the fastest. And for Asian countries, the shipping cycle is very long. Then establishing a reagent factory in Asia is the most effective and long term choice.
So today's Suzhou plant was built, all the equipment and accessories inside the Suzhou plant are imported, built according to Irish factory standards, the reagents produced need to be shipped to the Irish factory to do comparison and quality control. The treatment is very good.